Patents by Inventor Patricia E. W. Rohane

Patricia E. W. Rohane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING CUTANEOUS LUPUS USING AMINOISOINDOLINE COMPOUNDS
    Publication number: 20110104144
    Abstract: Methods of treating cutaneous lupus in a human are disclosed. Specific methods encompass the administration of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione (ACTIMID™), 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione (REVLIMID®), or cyclopropyl 2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindolin-4-yl}carboxamide, alone or alternatively, in combination with a second active agent.
    Type: Application
    Filed: January 11, 2011
    Publication date: May 5, 2011
    Applicant: CELGENE CORPORATION
    Inventors: Jerome B. Zeldis, Patricia E.W. Rohane, Peter H. Schafer
  • METHODS FOR THE TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-CARBOXAMIDE
    Publication number: 20090239926
    Abstract: Methods of treating, managing or preventing psoriasis or psoriatic arthritis are disclosed. Specific methods encompass the administration of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed.
    Type: Application
    Filed: March 24, 2009
    Publication date: September 24, 2009
    Inventors: Peter H. Schafer, George W. Muller, Patricia E.W. Rohane
  • Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
    Patent number: 7276529
    Abstract: Methods of treating, managing or preventing exercise-induced asthma are disclosed. Specific methods encompass the administration of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: October 2, 2007
    Assignee: Celgene Corporation
    Inventors: George W. Muller, Peter H. Schafer, Patricia E. W. Rohane
  • Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
    Patent number: 7208516
    Abstract: Methods of treating, managing or preventing psoriatic arthritis are disclosed. Specific methods encompass the administration of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: April 24, 2007
    Assignee: Celgene Corporation
    Inventors: George W. Muller, Peter H. Schafer, Patricia E. W. Rohane